IX Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 16-17 March 2015, Ufa

Lysova D.P., Lysova M.P., Miheeva N.V., Reshetko O.V. 6078

Pharmacoepidemiological analysis of secondary prevention of cerebral infarction according to age

Dolotovskaya P.V., Novikov D.E., Reshetko O.V., Furman N.V. 5798

Comparative analysis of the impact on the prognosis of patients with acute coronary syndrome drugs with proven efficacy in clinical practice

Baytman T.P., Ivlichev A.V., Levitan A.I., Reshetko O.V. 5904

Analysis of the actual practice of pharmacotherapy in patients with gastric ulcer and 12 duodenal ulcer in a central district hospital conditions

Miroshnichenko Y.V., Scherba M.P. 6148

Socio-economic analysis of the range of procurement of oral hypoglycemic agents in the military health care (the example of the western military region)

Kononov V.N., Miroshnichenko Y.V., Mustaev O.Z., Radionov E.O. 6223

Justification of the choice of drugs when refinement of medical cases

Goryachev A.B., Merkulov A.V., Miroshnichenko Y.V., Tihonov A.V. 6415

The new system of rationing drugs for russian navy

Goryachev A.B., Klochkova I.V., Miroshnichenko Y.V. 5857

The methodological approaches to the formation of armed forces first-aid kits and emergency medical cases

Reshetko O.V., Yakimova Y.N. 5810

Antibacterials for systemic use in the restrictive list of medicines

Reshetko O.V., Chernaya E.V. 5730

Estimation of structure destination of hypoglycemic agents in patients with type 2 diabetes mellitus and arterial hypertension

Ugrekhelidze D.T., Khabriev R.U., Yagudina R.I. 6513

Analysis of international experience of health technology assessment at the regional level

Ugrekhelidze D.T., Khabriev R.U., Yagudina R.I. 6187

Analysis of international experience of health technology assessment at the level of healthcare institutions

Kulikov A.Y., Ugrekhelidze D.T. 5898

Effect of different types of post-stroke spasticity therapy on decrease of economic losses of society

Sorokovikov I.V., Yagudina R.I. 5980

Pharmacoeconomic research of the use of the regimens of chemotherapy regimens in patients with multi-drug and extensively drug-resistant

Sanina I.I. 5759

Features of pharmacotherapy of infectious diseases during pregnancy in ambulatory practice

Kontsevaya A.V., Romanenko T.S. 5867

Low efficiency of antihypertensive therapy in patients of specialized cardiological institution as a factor of the irrational use of health care resources

Komarov E.A., Pochuprina A.A. 5716

Analysis of the effectiveness of the treatment of patients suffering from systemic lupus erythematosus

Pochuprina A.A. 5845

Cost analysis in patients with systemic lupus erythematosus in the Russian Federation

Pochuprina A.A., Protsenko M.V. 5908

Estimates of costs for correction of side effects arising from the use of ace inhibitors in patients with hypertension in the Russian Federation

Panfilova A.L. 5838

Analysis of indicators "willingness to pay threshold" in the health care system and pharmaceutical provision in Ukraine

Kulikov A.Y., Novikov I.V. 5949

Economic evaluation of glp-1 analogs as add-on to metformin therapy of diabetes mellitus

Kulikov A.Y., Novikov I.V. 5978

Economic evaluation of liraglutide as add-on to metformin therapy of diabetes mellitus

Kulikov A.Y., Novikov I.V. 6118

comparative pharmacoeconomic evaluation of drugs of the DPP-4 inhibitors

Murashko Y.I., Spichak I.V. 5916

Pharmacoeconomic study of drug supply of pregnant women with acute respiratory viral infections

Miheeva N.V., Reshetko O.V. 5798

Clinical and pharmacoeconomic efficiency thrombolytic therapy of cerebral infarction in clinical practice

Miheeva N.V., Reshetko O.V., Rizhenkova I.G. 6051

The effect of age of patients on pharmacotherapy of cerebrovascular accident in hospital

Ardenova N.N., Levitan A.I., Reshetko O.V. 5829

Pharmacoepidemiological analysis of pharmacotherapy of comorbid pathology of the musculoskeletal system in patients with rheumatoid arthritis

Komarov E.A. 5783

Health technology assessment in the treatment of bipolar disorder in the russian health care in terms of their impact on the budget

Komarov E.A. 5666

Estimation of consumption of atypical antipsychotic drugs used in the treatment of bipolar disorder, by analyzing the average daily maintenance dose (DDD)

Kulikov A.Y., Makarova E.I. 5813

The relevance of pharmacoeconomic evaluation of advantages of the application of easyhalers in bronchial asthma

Zolotovskaia I.A. 5657

Clinico-pharmacological justification for the use of anticoagulation in patients with atrial fibrillation undergoing cardioembolic stroke

Dereglazova Y.S., Spichak I.V. 5888

Pharmacoeconomic analysis of drug supply of children with juvenile arthritis

Babiy V.V., Yagudina R.I. 6167

The relevance of the pharmacoeconomic evaluation of highly active antiretroviral therapy (HAART) HIV-infected patients in the Russian Federation

Akimova Y.I. 5967

Budget impact analysis of the use of five-component and three component combination vaccines with acellular pertussis component in the regional calendar of preventive vaccinations as an example of Krasnodar for children at risk group

Abdrashitova G.T., Serpik V.G. 5913

IX Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation»
16-17 March 2015 year, Ufa